ABIVAX |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.82 EUR | +0.54% |
|
+4.66% | +50.92% |
| 11/04 | Morgan Stanley Adjusts Price Target on Abivax to $16 From $15, Maintains Equalweight Rating | MT |
| 08/04 | Transcript : ABIVAX Société Anonyme, 2023 Earnings Call, Apr 08, 2024 |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Neutral |
| Resistance | 15.18 | 15.18 | 18.38 |
| Spread/Res. | -2.37% | -2.37% | -19.37% |
| Spread/Supp. | +4.66% | +22.89% | +70.15% |
| Support | 14.16 | 12.06 | 8.710 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- ABVX Stock
- Charts Abivax
